Science Publications

Sign Up
Sign In
Submit
Global Journal of Medical Case Reports
Download PDF XML
  1. Home
  2. Journals
  3. Global Journal of Medical Case Reports
  4. Archive
  5. Volume 3, Number 1, 2023
  6. Article
  7. Table 2

Treatment by Ceftolozane/Tazobactam for Pseudomonas Aeruginosa Pneumonia Patients with or without Bacteremia

Table 2.

Antibiotic susceptibilities for the isolated Pseudomonasaeruginosa of Case 2
Day 0 Day 7
MIC S/I/R MIC S/I/R
AZT 8 S 16 I
PIPC 4 S >64 R
PIPC/TAZ ≦4 S >64 R
IPM 1 S 2 S
MEPM 0.25 S 0.5 S
CAZ 4 S >16 R
CFPM 2 S 16 I
CTLZ/TAZ ≦1/4 S ≦2/4 S
AMK ≦4 S ≦4 S
GM ≦2 S ≦2 S
MINO >8 R >8 R
LVFX 1 S 1 S
CPFX 0.25 S 0.25 S
ST 80 R 80 R

Abbreviations: MIC; minimum inhibitory concentration, S/I/R; susceptible/intermediate/resistant, AZT; aztreonam, PIPC; piperacillin, PIPC/TAZ; piperacillin/tazobactam, CAZ; ceftazidim, CFPM; cefepime, CTLZ/TAZ; ceftolozane/tazobactam, IPM; imipenem, MEPM; meropenem, MINO; minocycline LVFX; levofloxacin, CPFX; ciprofloxacin, AMK; amikacin, GM; gentamycin, ST; sulfamethoxazole/trimethoprim.
Abbreviations: MIC; minimum inhibitory concentration, S/I/R; susceptible/intermediate/resistant, AZT; aztreonam, PIPC; piperacillin, PIPC/TAZ; piperacillin/tazobactam, CAZ; ceftazidim, CFPM; cefepime, CTLZ/TAZ; ceftolozane/tazobactam, IPM; imipenem, MEPM; meropenem, MINO; minocycline LVFX; levofloxacin, CPFX; ciprofloxacin, AMK; amikacin, GM; gentamycin, ST; sulfamethoxazole/trimethoprim.